BiomX
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Einstein St Fl 4, Ness Ziona, Central...Phone Number
+972 723942377Website
www.biomx.comRevenue
-Stock Symbol
PHGEIndustry
About BiomX
BiomX Org Chart
Is BiomX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BiomX is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BiomX
Product Launch: Get notified when BiomX launches new products
Earning: See what the market has to say on BiomX recently announced quarterly report
BiomX, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if BiomX had a recent Job posting/layoffs
Check if BiomX has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once BiomX has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
BiomX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BiomX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BiomX.
BiomX financials insights
Gather financial insights about BiomX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$24M
Series B
$32M
Other Financing Round
$12M
Private Equity
$3.3M
BiomX Tech Stack
A closer look at the technologies used by BiomX
Most Recent Scoops
BiomX News & Media
BiomX Announces NYSE American Acceptance of Plan to Regain Compliance
NETANYA, Israel, June 12, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that the Company’s previously-submitted plan (the “Plan”) to regain compliance with NYSE American LLC’s listing standards was accepted, including plan compliance period through September 25, 2027.BiomX: Zorronet’s AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events
Idan Wasserman contends that major global events require AI systems that can understand context, reduce false alarms, and identify relevant security alerts Idan Wasserman contends that major global events require AI systems that can understand context, reduce false alarms, and identify relevant security alertsAnother Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland security Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland securityZorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence
The company introduces an expanded on-premise and hybrid C5ISR suite that enables local AI processing, command automation, and response coordination for defense, security, and critical infrastructure The company introduces an expanded on-premise and hybrid C5ISR suite that enables local AI processing, command automation, and response coordination for defense, security, and critical infrastructure
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding BiomX
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis and colorectal cancer. BiomX discovers and validates proprietary bact... Read More
